Aprea Therapeutics
APRE
APRE
26 hedge funds and large institutions have $1.11M invested in Aprea Therapeutics in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
88% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 8
92% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 13
Holders
26
Holding in Top 10
–
Calls
$385K
Puts
$8K
Top Sellers
| 1 | -$54K | |
| 2 | -$37K | |
| 3 | -$36K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$29.8K |
| 5 |
Two Sigma Investments
New York
|
-$28.4K |